ISS OBT-MED CNTGCY DRILL (Photo Credit: Expedition 52 Paolo Nespoli @astro_paolo Twitter)
Health check for Paolo Nespoli using Tempus Pro (Photo Credit: ESA Multimedia)
Project Name: Tempus ALS
Customer: ESA (prime contractor)
Objective: Flight Demonstrator of TEMPUS ALS, an instrument for integrated monitoring of human physiological parameters for future space exploration missions.
Description:
The Tempus ALS is a modular advanced telemedicine vital signs monitor with multiple capabilities that are consistent with many of the requirements of current (planned) and future human exploration missions (e.g., compact, robust, scalable, adaptable, evolutive, ease of use). The device is manufactured by RDT Ltd., a Philips Company (UK) and stems from a demonstration project supported by ESA’s Advanced Research in Telecommunications Systems (ARTES) – Business Applications and Space Solutions (BASS) Programme. Objective of the contract with Kayser Space is to deliver the integration, qualification, acceptance and mission support of a flight demonstration of TEMPUS ALS on the International Space Station (ISS). Testing on the ISS shall support the demonstration that a single device can enable the more efficient execution physiological parameters monitoring in a real operational environment, considering system preparation, operation, ability to support real-time data transmissions and stowage. Furthermore, the device should enhance the on-orbit capabilities to respond to contingency. To demonstrate this, the Tempus ALS will be incorporated into a simulated on-orbit medical emergency drill to demonstrate the advantage compared with current ISS capabilities. Additional features of the Tempus ALS that can complete or enhance the response to life-threatening on orbit conditions will also be tested. Finally, testing on ISS is a necessary step for TRL advancement from 6 to 9 and for potential future use during future exploration-class missions.
